International investing, especially emerging markets, has had a difficult time recently, so a few Board members are starting to get upset about the current allocation to this long term, diversifying asset. What does this asset class mean for the insurer’s enterprise risk management? What about emerging markets bonds versus equity? Due to the volatility of these asset classes, should a passive or active approach be preferred?